Ocular Therapeutix (OCUL) Tops Q3 EPS by 3c

Ocular Therapeutix (NASDAQ: OCUL) reported Q3 EPS of ($0.23), $0.03 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $12.15 million versus the consensus estimate of $12.45 million.

For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• Piper Sandler Assumes Provident Financial Holdings (PROV) at Neutral
• Johnson & Johnson (JNJ) PT Raised to $270 at Guggenheim